Stock listing
MSB Stock Price, News, Filings & Events — Mesoblast Limited
Selected listing: MSB · ASX · AUD · AU
This page tracks Mesoblast Limited's MSB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MSB:ASX. MSB:ASX is the stock-level entry point for investors researching Mesoblast Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mesoblast Limited (Ticker: MSB) is a public company based in Australia, focused on developing innovative cell-based therapies. With a market capitalization of approximately AUD 2.1 billion, the company is dedicated to addressing unmet medical needs in various therapeutic areas. Mesoblast's research and development efforts aim to advance treatments for conditions such as heart disease and orthopedic disorders.
- Ticker
- MSB:ASX
- Asset type
- Stock
- Market cap
- $2.32B
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
Mesoblast Limited MSB:ASX stock context
This page tracks Mesoblast Limited's MSB:ASX listing on ASX in AUD for AU, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following MSB:ASX. MSB:ASX is the stock-level entry point for investors researching Mesoblast Limited, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Mesoblast Limited (Ticker: MSB) is a public company based in Australia, focused on developing innovative cell-based therapies. With a market capitalization of approximately AUD 2.1 billion, the company is dedicated to addressing unmet medical needs in various therapeutic areas. Mesoblast's research and development efforts aim to advance treatments for conditions such as heart disease and orthopedic disorders.
Latest news from Mesoblast Limited
Mesoblast Reports Substantial Revenue Growth to US$120M
August 26, 2026
Major Milestone Treatment Completed in P3 Trial for CLBP
August 16, 2026
Mesoblast Reports Ryoncil® Net Revenues of US$36M for the Quarter and US$115M for First Full Year of Product Launch
July 29, 2026
Mesoblast Achieves Target of 300 Treated Patients in Pivotal Phase 3 Trial for Chronic Low Back Pain
July 13, 2026
Ryoncil® Delivers Net Revenue of US$36M for the Fourth Quarter Ended 30 June 2026
July 9, 2026
Research Mesoblast Limited
Mesoblast Limited investor report
Review AI stock analysis and investor report context for MSB:ASX.
Mesoblast Limited company profile
View the public company page for Mesoblast Limited on 6ix.
Mesoblast Limited news
Read company news and market updates connected to Mesoblast Limited.
Mesoblast Limited investor events
Find investor webinars, events, and replay context for Mesoblast Limited.
Alternate listings
MESO:NASDAQ
US · USD
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB:GETTEX
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
MEOBF:OTC
US · USD
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
A0DNPW:LSX
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
A0DNPW:LS
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
MESO:BOATS
US · USD
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB1:GETTEX
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB:TRADEGATE
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB:FWB
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB:BX
CH · CHF
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB:DUS
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.
LWB1:FWB
DE · EUR
Alternate listing for Mesoblast Limited; the primary context on this page is MSB:ASX.